海辰药业
(300584)
| 流通市值：45.64亿 | | | 总市值：66.70亿 |
| 流通股本：8211.07万 | | | 总股本：1.20亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 471,526,892.93 | 308,572,571.42 | 142,649,339.94 | 504,360,394.59 |
| 营业收入 | 471,526,892.93 | 308,572,571.42 | 142,649,339.94 | 504,360,394.59 |
| 二、营业总成本 | 424,895,894.17 | 268,183,609.26 | 124,158,918.05 | 454,644,738.59 |
| 营业成本 | 78,373,687.38 | 43,561,139.37 | 19,842,260.49 | 84,980,990.82 |
| 税金及附加 | 10,224,134.89 | 6,608,200.11 | 3,185,104.11 | 10,641,872.71 |
| 销售费用 | 195,516,916.62 | 128,610,941.18 | 56,390,082.47 | 201,766,882.46 |
| 管理费用 | 104,692,101.85 | 69,016,888.31 | 38,657,009.14 | 107,887,139.55 |
| 研发费用 | 31,204,448.18 | 16,902,144.44 | 4,331,960.14 | 40,275,869.51 |
| 财务费用 | 4,884,605.25 | 3,484,295.85 | 1,752,501.7 | 9,091,983.54 |
| 其中:利息费用 | 4,924,553.61 | 3,525,526.13 | 1,774,305.64 | 8,983,022.82 |
| 其中:利息收入 | 49,557.95 | 37,528.3 | 21,383.36 | 113,603.48 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -2,763,924.66 | -1,225,456.46 | -7,469.68 | 3,318.69 |
| 资产处置收益 | 482,279.37 | 482,279.37 | - | - |
| 资产减值损失(新) | -14,640,368.67 | -9,351,690.62 | -3,931,326.87 | -9,884,051.74 |
| 信用减值损失(新) | 1,442,428.33 | 716,669.92 | 1,437,594.09 | 834,439.48 |
| 其他收益 | 723,521.08 | 664,082.56 | 528,271.12 | 1,138,876.31 |
| 四、营业利润 | 31,874,934.21 | 31,674,846.93 | 16,517,490.55 | 41,808,238.74 |
| 加:营业外收入 | 3,578,515.86 | 31,311.29 | 19,301.18 | 570,272.45 |
| 减:营业外支出 | 603,476.23 | 375,787.15 | 184,971.08 | 1,348,204.26 |
| 五、利润总额 | 34,849,973.84 | 31,330,371.07 | 16,351,820.65 | 41,030,306.93 |
| 减:所得税费用 | 2,655,340.7 | 2,451,894.32 | 1,388,950.76 | 867,335.68 |
| 六、净利润 | 32,194,633.14 | 28,878,476.75 | 14,962,869.89 | 40,162,971.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 32,194,633.14 | 28,878,476.75 | 14,962,869.89 | 40,162,971.25 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 32,678,503.32 | 29,157,742.41 | 15,036,959.76 | 40,217,910.88 |
| 少数股东损益 | -483,870.18 | -279,265.66 | -74,089.87 | -54,939.63 |
| 扣除非经常损益后的净利润 | 29,543,089.6 | 28,851,005.73 | 15,001,968.14 | 40,617,505.22 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.27 | 0.24 | 0.13 | 0.34 |
| (二)稀释每股收益 | 0.27 | 0.24 | 0.13 | 0.34 |
| 九、综合收益总额 | 32,194,633.14 | 28,878,476.75 | 14,962,869.89 | 40,162,971.25 |
| 归属于母公司股东的综合收益总额 | 32,678,503.32 | 29,157,742.41 | 15,036,959.76 | 40,217,910.88 |
| 归属于少数股东的综合收益总额 | -483,870.18 | -279,265.66 | -74,089.87 | -54,939.63 |
| 公告日期 | 2025-10-23 | 2025-08-23 | 2025-04-21 | 2025-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |